W
GRTX

WealthCollab’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

WealthCollab’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,918
Closed -$570 – 959
2023
Q4 		$570 Buy
+3,918
New +$608 ﹤0.01% 855

Other funds holding GRTX

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WealthCollab's GRTX Position: Q1 2024 in Review

WealthCollab sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 3,918 shares — an estimated $570 sold.

WealthCollab first reported a position in GRTX in Q4 2023 and held it in 1 quarter. The position peaked at $570 in Q4 2023. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

  • WealthCollab reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • WealthCollab sold 3,918 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $570.
  • WealthCollab first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • WealthCollab's Galera Therapeutics, Inc. Common Stock position peaked at $570 in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on WealthCollab's 13F filing for Q1 2024, filed 10 May 2024.